By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Speedel Group 

Hirschgasslein 11

Basel    CH - 4051  Switzerland
Phone: 41-61-206-40-00 Fax: 41-61-206-40-01


Company News
Speedel Group Release: SPP100 (Tekturna/Rasilex) Reduces Left Ventricular Hypertrophy 4/1/2008 9:31:18 AM
Speedel Group Holds Annual R&D Day 3/31/2008 11:17:50 AM
Speedel Group Announces A New Series Of Renin Inhibitors 2/16/2006 11:13:20 AM
Speedel Group Release: SPP301 Phase IIb Results In Diabetic Nephropathy Presented At ASN 11/14/2005 10:39:21 AM
Speedel Brings In CHF47.8M To Advance Pipeline Projects10/19/2005 5:12:49 PM
Speedel Raises CHF 47.8 Million In Private Funding Round10/19/2005 5:12:47 PM
Novartis' (NVS) Latest Phase III And II Data With SPP100 (Aliskiren) Reconfirm Speedel's Previous Clinical Studies For The Treatment Of Hypertension10/19/2005 5:12:31 PM
Professor Karl-Heinz Altmann Joins Speedel Scientific & Technical Advisory Board10/19/2005 5:12:16 PM
Speedel Group Release: Successful Outcome Of Aliskiren, The First-In-Class Renin Inhibitor, Vs. Irbesartan, In A 650 Patient Hypertension Study, Recently Completed By Novartis (NVS)10/19/2005 5:10:49 PM
Speedel Pharmaceuticals, Inc. Appoints Rolf Hanggi To Board Of Directors10/19/2005 5:10:27 PM